Micro Labs USA Launches Two New Glaucoma Drugs
BASKING RIDGE, N.J., Sept. 25, 2020 /PRNewswire/ -- Micro Labs USA Inc. announces its presence in the US Ophthalmic market of $8.5 billion (source: IQVIA MAT July 2020), by launching two products - Dorzolamide 2% and Dorzolamide-Timolol 22.3-6.8 mg/mL Micro Labs is...
Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presentations 118mL and 473mL)
BASKING RIDGE, N.J. and HAUPPAGUE, N.Y., May 13, 2020 /PRNewswire/ -- Micro Labs USA, Inc. and Saptalis Pharmaceuticals, LLC. are strengthening their association with the launch of Metformin Oral Solution in the US market. Metformin Oral Solution is indicated as an...
Micro Labs, Saptalis ink generics deal, launch first product
A new generics partnership is bringing oral liquid and topical products to the market. Micro Labs USA and Saptalis Pharmaceuticals have formed a strategic collaboration to launch single-source and multisource generics in the United States, as well as launched the...
Armas and Micro Labs Announce Collaboration To Launch Generic Injectables to U.S. Market
MANALAPAN, N.J. and BASKING RIDGE, N.J., May 28, 2019 /PRNewswire/ -- Armas Pharmaceuticals Inc. and Micro Labs USA, Inc. have announced today, the forming of a strategic collaboration to bring select multisource injectable products to the U.S. market. The first...
